Detailed Structural Characterization of Unbound Protein Phosphatase 1 Inhibitors

被引:54
作者
Dancheck, Barbara [1 ]
Naim, Angus C. [2 ]
Peti, Wolfgang [1 ]
机构
[1] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA
[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA
关键词
D O I
10.1021/bi801308y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein phosphatase 1 (PP1) is an essential and ubiquitous serine/threonine protein phosphatase that is regulated by more than 100 known inhibitor and targeting proteins. It is currently unclear how protein inhibitors distinctly and specifically regulate PP1 to enable rapid responses to cellular alterations. We demonstrate that two PP1 inhibitors, I-2 and DARPP-32, belong to the class of intrinsically unstructured proteins (IUPs). We show that both inhibitors have distinct preferences for transient local and long-range structure. These preferences are likely their structural signature for their interaction with PP1. Furthermore, we show that upon phosphorylation of Thr(34) in DARPP-32, which turns DARPP-32 into a potent inhibitor of PP1, neither local nor long-range structure of DARPP-32 is altered. Therefore, our data suggest a role for these transient three-dimensional topologies in binding mechanisms that enable extensive contacts with PP1's invariant surfaces. Together, these interactions enable potent and selective inhibition of PP1.
引用
收藏
页码:12346 / 12356
页数:11
相关论文
共 75 条
[41]   Structural analysis of the protein phosphatase 1 docking motif: Molecular description of binding specificities identifies interacting proteins [J].
Meiselbach, H ;
Sticht, H ;
Enz, R .
CHEMISTRY & BIOLOGY, 2006, 13 (01) :49-59
[42]   Emerging roles of nuclear protein phosphatases [J].
Moorhead, Greg B. G. ;
Trinkle-Mulcahy, Laura ;
Ulke-Lemee, Annegret .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (03) :234-244
[43]   The role of DARPP-32 in the actions of drugs of abuse [J].
Nairn, AC ;
Svenningsson, P ;
Nishi, A ;
Fisone, G ;
Girault, JA ;
Greengard, P .
NEUROPHARMACOLOGY, 2004, 47 :14-23
[44]  
NEYROZ P, 1993, J BIOL CHEM, V268, P24022
[45]   Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threohine residue [J].
Ohki, SY ;
Eto, M ;
Shimizu, M ;
Takada, R ;
Brautigan, DL ;
Kainosho, M .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 326 (05) :1539-1547
[46]   Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation [J].
Ohki, SY ;
Eto, M ;
Kariya, E ;
Hayano, T ;
Hayashi, Y ;
Yazawa, M ;
Brautigan, D ;
Kainosho, M .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 314 (04) :839-849
[47]   MOLECULAR-DYNAMICS ANALYSIS OF NMR RELAXATION IN A ZINC-FINGER PEPTIDE [J].
PALMER, AG ;
CASE, DA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (23) :9059-9067
[48]  
PARK IK, 1994, J BIOL CHEM, V269, P28919
[49]  
PARK IK, 1994, J BIOL CHEM, V269, P944
[50]   Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost [J].
Peti, Wolfgang ;
Page, Rebecca .
PROTEIN EXPRESSION AND PURIFICATION, 2007, 51 (01) :1-10